Protagenic Therapeutics Current Assets

Protagenic Therapeutics (PTIX) currently reports a current assets of $190K as of September 2026. That compares with $2.9M in the prior-year period — down 93.4% year over year. Use the charts on this page to explore Protagenic Therapeutics's current assets history and peer comparisons.

Protagenic Therapeutics's current assets decreased from $2.9M to $190K — a 93.4% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Protagenic Therapeutics reported $190K in current assets as of September 2026. That compares with $2.9M in the prior-year period — down 93.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $190K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Protagenic Therapeutics, and consider following PTIX for alerts when major investors trade the stock.

Protagenic Therapeutics is classified in the Industrials sector. On current assets, it currently shows $190K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing PTIX with unrelated industries.